NCT03926429|Completed
Features and Outcomes of Patients With Reactive Arthritis
A Bicentre Retrospective Study of Features and Outcomes of Patients With Reactive Arthritis
Loading search results
A Bicentre Retrospective Study of Features and Outcomes of Patients With Reactive Arthritis
Sponsor study identifier
observational
58
1 country
2
Study Start
February 1, 2013
Actual (reported)Primary Completion
December 31, 2014
Actual (reported)Study Completion
December 31, 2014
Actual (reported)The aim of this study is to assess the incidence and the clinical and therapeutic characteristics of reactive arthritis and to compare them with those of a historical cohort. We hypothesised that improved hygiene together with prevention and treatment of sexually transmitted infections may have decreased the incidence of reactive arthritis.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 31, 2014
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
February 1, 2013
Actual (reported)December 31, 2014
Actual (reported)December 31, 2014
Actual (reported)April 19, 2019
Actual (reported)April 24, 2019
Actual (reported)To determine the incidence of reactive arthritis in patients hospitalised in the rheumatology department
Incidence of reactive arthritis in patients hospitalised in the rheumatology department
December 2014
The following variables will be retrospectively assessed by medical record review using a standardised data collection form:demographics; gender, age; family or personal history of spondyloarthritis, psoriasis, uveitis, inflammatory bowel disease; clinical presentation; mono, oligo or polyarthritis, dactylitis, inflammatory joint pain, enthesopathy, axial symptoms, fever, extra-articular manifestations (conjunctivitis, anterior uveitis, circinate balanitis, skin rash); time interval between infection and musculoskeletal manifestations; causal microorganism if known, or triggering event; HLA-B27; radiographic sacroiliitis; treatments and outcomes (complete recovery at one year follow-up, relapse within 6 months after onset, or spondyloarthritis according to the ASAS criteria).
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Patients with active reactive arthritis
CHU de Besançon
Besançon, France
Centre Hospitalier Lyon Sud
Pierre-Bénite, France
Fabienne COURY-LUCAS, MD
Hospices Civils de Lyon
58 participants (actual enrollment reported by the registry).
First Submitted
April 19, 2019
First Posted
April 24, 2019
Study Start
February 1, 2013
Actual (reported)Physiotherapy and Capsulitis
Contact the study team to confirm eligibility.
Primary Completion
December 31, 2014
Actual (reported)Study Completion
December 31, 2014
Actual (reported)Last Updated
April 24, 2019
Record last verified: 2019-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: